Loading
Fuller H B Co Stock: price and insider trades · United States
9 insiders bought €1.0M of shares over the last 90 days, the latest by Malik Muhammad Shahbaz, filed 19 Oct 2026.
Cluster: 9 buyers in 30 daysInsider Decl.
1,386
Thresholds
n/a
Buy Volume
€2M
19 ops. · all time
Sell Volume
€72M
135 ops. · all time
Who traded when
BuySaleCeleste Beeks Mastin2 buys
Du Xinyu2 sales
Joao Magalhaes2 sales
Nathan D. Weaver2 sales
Srilata Zaheer2 buys
Trangsrud Teresa J. Rasmussen2 buys
+10 other insiders
Since the insiders bought
- -8.3%Entry US$62.78 · Close at T+90 US$57.57
- -16.5%Entry US$59.28 · Close at T+365 US$49.47
- +13.3%Entry US$59.62 · Close at T+365 US$67.56
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Fuller H B Co Strong Buy (bullish), based on 7 analysts. Average price target: US$68.29.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 11,319 of 26,248 companies
55.1
score / 100
Value64
Quality46
FCF yld4.5%
Earn yld5.6%
EV/EBITDA9.1x
ROE9.6%
Gross mgn31%
Net mgn4.4%
Debt/EBITDA3.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended November 2025 · cache
US$50.57
Analyst consensus
7 analystsStrong buy
US$62.00Target US$68.29(+35%)US$80.00
Income statement
RevenueUS$3.5B
Gross profitUS$1.1B31% margin
EBITDAUS$527.1M15% margin
Net incomeUS$152M5.6% margin
Valuation
PER (trailing)14.1x
PER (forward)9.8x
P/Book1.3x
Beta0.99
Balance sheet & cash
Market capUS$2.7B
Total debtUS$2.1B
Free Cash FlowUS$121.2M
Debt / Equity101%
Profitability & ownership
ROE9.6%
ROA5.0%
% insiders0.3%
% institutions106.8%
Last declaration on 19 October 2026
Declarations1,386 total
478.659 shares@ US$52.22920.0009% mcap1.6% of flowCommon StockSEC:0001225208-26-008441:0
Canonical exit: 14 Jan 2027 (T+90)
10,000 shares@ US$50.000.018% mcap100.0% of flowCommon StockSEC:0001225208-26-008325:0
Canonical exit: 5 Jan 2027 (T+90)
453 shares@ US$50.200.0008% mcap3.6% of flowCommon StockSEC:0001225208-26-008295:0
202 shares@ US$50.200.0004% mcap1.6% of flowCommon StockSEC:0001225208-26-008295:1
19 shares@ US$50.200.0000% mcap0.1% of flowCommon StockSEC:0001225208-26-008295:2
61 shares@ US$50.200.0001% mcap0.5% of flowCommon StockSEC:0001225208-26-008295:3
141 shares@ US$50.200.0003% mcap1.1% of flowCommon StockSEC:0001225208-26-008295:4
2,000 shares@ US$49.6250.0037% mcap47.9% of flowCommon StockSEC:0001225208-26-008046:0
Canonical exit: 28 Dec 2026 (T+90)
464.599 shares@ US$49.500.0009% mcap100.0% of flowCommon StockSEC:0001225208-26-008045:0
Canonical exit: 29 Dec 2026 (T+90)
2,000 shares@ US$49.410.0037% mcap100.0% of flowCommon StockSEC:0001225208-26-008014:0
Canonical exit: 27 Dec 2026 (T+90)
2,000 shares@ US$49.060.0037% mcap56.3% of flowCommon StockSEC:0001225208-26-008011:0
Canonical exit: 27 Dec 2026 (T+90)
1,542 shares@ US$48.95870.0028% mcap22.6% of flowCommon StockSEC:0001225208-26-008013:0
Canonical exit: 27 Dec 2026 (T+90)
40 shares@ US$49.97260.0001% mcap1.1% of flowCommon StockSEC:0001225208-26-008011:1
Canonical exit: 28 Dec 2026 (T+90)
500 shares@ US$48.980.0009% mcap7.3% of flowCommon StockSEC:0001225208-26-008013:1
Canonical exit: 27 Dec 2026 (T+90)
2,030 shares@ US$49.340.0037% mcap54.4% of flowCommon StockSEC:0001225208-26-008015:0
Canonical exit: 27 Dec 2026 (T+90)
2,005 shares@ US$49.86760.0037% mcap56.0% of flowCommon StockSEC:0001225208-26-008012:0
Canonical exit: 28 Dec 2026 (T+90)
4,976 shares@ US$50.100.0091% mcap7.0% of flowCommon StockSEC:0001225208-26-007076:0
4,585 shares@ US$53.570.0090% mcap6.9% of flowCommon StockSEC:0001225208-26-007076:1
9,561 shares@ US$62.05750.022% mcap16.6% of flowCommon StockSEC:0001225208-26-007076:2
9,561 shares@ US$62.05750.022% mcap16.6% of flowCommonSEC144:0001921094-26-000834
1,658 shares@ US$50.100.0031% mcap39.3% of flowCommon StockSEC:0001225208-26-006556:0
1,000 shares@ US$65.830.0021% mcap27.2% of flowCommon StockSEC:0001225208-26-004571:0
5,170 shares@ US$57.0810.0% of flowCommon StockSEC:0001225208-26-004429:0
Canonical exit: 6 Jul 2026 (T+90)
245 shares@ US$63.064.0% of flowCommon StockSEC:0001225208-26-001305:1
519 shares@ US$63.0615.0% of flowCommon StockSEC:0001225208-26-001305:0
25 of 1386 declarations
About Fuller H B Co
From September 28 to October 16, 2026, 9 filers at Fuller H B Co bought EUR 1,012,760 in total, more than half of the record's 19 purchases (EUR 1,957,235, median EUR 86,774). The largest is by R. Jeffrey Bailly (Director), EUR 444,550 on October 7, 2026; Celeste Beeks Mastin (President and CEO) bought EUR 252,514 on April 7, 2026 and EUR 183,689 on April 1, 2025. 11 purchase filings are flagged as cluster buys.
Sales are more numerous and heavier: 135 sales worth EUR 71,635,856 (median EUR 285,551), or 12% purchases among open-market trades. James Owens (President and CEO) sold EUR 5,659,152 on November 7, 2022 and EUR 4,783,021 on November 11; Steven Kenny (Senior VP, Emerging Markets) EUR 2,703,210 on March 29, 2016. Robert J. Martsching (VP, Corporate Controller) is the most frequent filer, with 131 filings including 12 sales.
Read moreShow less
This US chemicals and materials company, valued at USD 2.7 billion, has 1,386 filings since 2016, including 618 option exercises and 588 grants. Annual volume reaches 180 filings in 2019, against 92 in 2023. Insiders hold 0.3% of the capital. Last twelve months: 119 filings, 12 purchases, 3 sales.
